Cargando…

Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer

OBJECTIVE: The aim of this study was to investigate the correlations between molybdenum target X-ray mammography features and the expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in invasive breast cancer (IBC) and their clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Tailaiti, Gulijire, Maimaiti, Gulanbaier, Aikeremu, Youlituzi, Tuerdi, Batuer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236255/
https://www.ncbi.nlm.nih.gov/pubmed/34188531
http://dx.doi.org/10.2147/IJGM.S314055
_version_ 1783714501450792960
author Tailaiti, Gulijire
Maimaiti, Gulanbaier
Aikeremu, Youlituzi
Tuerdi, Batuer
author_facet Tailaiti, Gulijire
Maimaiti, Gulanbaier
Aikeremu, Youlituzi
Tuerdi, Batuer
author_sort Tailaiti, Gulijire
collection PubMed
description OBJECTIVE: The aim of this study was to investigate the correlations between molybdenum target X-ray mammography features and the expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in invasive breast cancer (IBC) and their clinical significance. METHODS: The correlations between the mammographic features and expressions of ER, PR, and HER2 in 378 cases of IBC confirmed by pathology were analyzed retrospectively. RESULTS: The differences in the ER, PR, and HER2 positive expression between gland types were statistically significant (P < 0.05). The expression of ER was positively correlated with the presence of nipple depression (P < 0.05). Moreover, ER and PR expressions were positively correlated with the absence of axillary lymph node enlargement (P < 0.05) and negatively correlated with the maximum tumor diameter (P < 0.05). CONCLUSION: The mammographic features of IBC are correlated with the expression of immunity indices ER, PR, and HER2 and reflect several pathological features.
format Online
Article
Text
id pubmed-8236255
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82362552021-06-28 Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer Tailaiti, Gulijire Maimaiti, Gulanbaier Aikeremu, Youlituzi Tuerdi, Batuer Int J Gen Med Original Research OBJECTIVE: The aim of this study was to investigate the correlations between molybdenum target X-ray mammography features and the expressions of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) in invasive breast cancer (IBC) and their clinical significance. METHODS: The correlations between the mammographic features and expressions of ER, PR, and HER2 in 378 cases of IBC confirmed by pathology were analyzed retrospectively. RESULTS: The differences in the ER, PR, and HER2 positive expression between gland types were statistically significant (P < 0.05). The expression of ER was positively correlated with the presence of nipple depression (P < 0.05). Moreover, ER and PR expressions were positively correlated with the absence of axillary lymph node enlargement (P < 0.05) and negatively correlated with the maximum tumor diameter (P < 0.05). CONCLUSION: The mammographic features of IBC are correlated with the expression of immunity indices ER, PR, and HER2 and reflect several pathological features. Dove 2021-06-23 /pmc/articles/PMC8236255/ /pubmed/34188531 http://dx.doi.org/10.2147/IJGM.S314055 Text en © 2021 Tailaiti et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tailaiti, Gulijire
Maimaiti, Gulanbaier
Aikeremu, Youlituzi
Tuerdi, Batuer
Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
title Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
title_full Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
title_fullStr Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
title_full_unstemmed Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
title_short Molybdenum Target X-Ray Features and Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 in Invasive Breast Cancer
title_sort molybdenum target x-ray features and estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 in invasive breast cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236255/
https://www.ncbi.nlm.nih.gov/pubmed/34188531
http://dx.doi.org/10.2147/IJGM.S314055
work_keys_str_mv AT tailaitigulijire molybdenumtargetxrayfeaturesandestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2ininvasivebreastcancer
AT maimaitigulanbaier molybdenumtargetxrayfeaturesandestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2ininvasivebreastcancer
AT aikeremuyoulituzi molybdenumtargetxrayfeaturesandestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2ininvasivebreastcancer
AT tuerdibatuer molybdenumtargetxrayfeaturesandestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2ininvasivebreastcancer